Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014345
Filing Date
2024-11-05
Accepted
2024-11-05 09:05:51
Documents
101
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20240930x10q.htm   iXBRL 10-Q 2087824
2 EX-10.1 ipsc-20240930xex10d1.htm EX-10.1 76331
3 EX-10.2 ipsc-20240930xex10d2.htm EX-10.2 230593
4 EX-10.3 ipsc-20240930xex10d3.htm EX-10.3 39459
5 EX-31.1 ipsc-20240930xex31d1.htm EX-31.1 14643
6 EX-31.2 ipsc-20240930xex31d2.htm EX-31.2 14440
7 EX-32.1 ipsc-20240930xex32d1.htm EX-32.1 6982
8 EX-32.2 ipsc-20240930xex32d2.htm EX-32.2 6938
9 GRAPHIC ipsc-20240930xex10d2001.jpg GRAPHIC 703
10 GRAPHIC ipsc-20240930xex10d3001.jpg GRAPHIC 939
11 GRAPHIC ipsc-20240930xex31d1001.jpg GRAPHIC 939
12 GRAPHIC ipsc-20240930xex31d2001.jpg GRAPHIC 939
  Complete submission text file 0001558370-24-014345.txt   10055559

Data Files

Seq Description Document Type Size
13 EX-101.SCH ipsc-20240930.xsd EX-101.SCH 64535
14 EX-101.CAL ipsc-20240930_cal.xml EX-101.CAL 75377
15 EX-101.DEF ipsc-20240930_def.xml EX-101.DEF 257825
16 EX-101.LAB ipsc-20240930_lab.xml EX-101.LAB 591269
17 EX-101.PRE ipsc-20240930_pre.xml EX-101.PRE 461217
104 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20240930x10q_htm.xml XML 1747676
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 241425935
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)